PMC9974269_01
T2-weighted sagittal MR of the neck showing the spinal lesion at the level of T5.
CRIONM2023-9647892.001.jpg
PMC9974269_01_CRIONM2023-9647892.001.jpg
fig1
On T2-weighted MRI, the signal intensity of this lesion was heterogenous with a bright thick signal on the outer aspect of the lesion and low central signal intensity (Figure 1).
T2-weighted sagittal (view/section) MRI of the neck showing the pleural lesion.
CRIONM2023-9647892.002.jpg
PMC9974269_01_CRIONM2023-9647892.002.jpg
fig2
The lesion had similar signal characteristics as the spinal lesion, along with areas of calcifications on contrast-enhanced CT. The lesion measured 3.7 x 3.4 x 3.4 cm in the AP, transverse, and longitudinal axes, respectively (Figure 2).
High-resolution chest CT shows a pulmonary nodule in the right middle lung lobe denoting pulmonary metastasis.
CRIONM2023-9647892.003.jpg
PMC9974269_01_CRIONM2023-9647892.003.jpg
fig3
Unfortunately, follow-up imaging on the 15th of July 2019 showed the development of a new metabolically active metastatic lesion in the right middle pulmonary lobe and left lower paracardiac lung lobe, and progression of the size and metabolic activity of the lesions denoting lung metastasis (Figures 3 and 4).
High-resolution chest CT showing another left lower lung lobe paracardiac lung mass denoting another metastatic lesion.
CRIONM2023-9647892.004.jpg
PMC9974269_01_CRIONM2023-9647892.004.jpg
fig4
Unfortunately, follow-up imaging on the 15th of July 2019 showed the development of a new metabolically active metastatic lesion in the right middle pulmonary lobe and left lower paracardiac lung lobe, and progression of the size and metabolic activity of the lesions denoting lung metastasis (Figures 3 and 4).